Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN118164864A offers nitro-free Roxadustat intermediate synthesis. Enhances safety, reduces cost, and ensures supply chain reliability for global pharmaceutical partners.
Patent CN106588774B reveals stable catalyst for iminodibenzyl. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN113527155B reveals a green Gliclazide synthesis method. It offers cost reduction in API manufacturing and ensures high-purity pharmaceutical intermediates supply.
Patent CN111676487B reveals metal-free electrooxidation for 2-aminoindoles. Green aqueous process reduces cost and improves supply chain reliability for pharma intermediates.
Patent CN113105344B reveals a weak acid catalyzed route for high-purity Voglibose Impurity II, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101747364B details a high-yield synthesis route for gamma-piperazinepropyl methyldimethoxysilane, offering cost reduction and supply chain reliability for silicone additive manufacturing.
Advanced zinc-complexation method for high-purity 3-N-ethyl Gentamicin C1a. Reduces impurities and enhances supply chain reliability for Etimicin production.
Patent CN118726300A reveals a novel transaminase mutant for producing agrochemical intermediates with high optical purity and reduced manufacturing costs.
Novel low-cost process for Rimegepant intermediate using urea. Reduces raw material costs and enhances industrial scalability for pharmaceutical supply chains globally.
Patent CN114075209A reveals a novel route for Nalbuphine related substances. Enhance supply chain reliability and reduce manufacturing costs with this advanced method.
Patent CN112194585A reveals a high-yield reductive amination route for Bromhexine Hydrochloride, eliminating corrosive thionyl chloride and enhancing supply chain stability.
Novel five-step route for Ticagrelor intermediate V reduces cost and improves yield for pharmaceutical supply chains globally ensuring high purity and reliability.
Patent CN102603683A reveals novel furan synthesis for antibacterial drugs. Discover cost reduction in antibacterial drug manufacturing and high-purity intermediate supply chain solutions.
Patent CN117965476A details a novel reductive aminase mutant for high-purity rotigotine intermediate synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover a novel synthesis route for trans-4-Boc-aminocyclohexanecarboxylic acid via patent CN113402428A. Achieve >95% stereoselectivity and streamlined manufacturing for peptide drugs.
Patent CN104447791B reveals a low-cost D-biotin preparation method. Discover supply chain advantages and high-purity manufacturing capabilities for global procurement.
Novel aminotransferase patent enables high-purity sitagliptin intermediate production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Advanced synthesis of Epacadostat intermediates via patent CN108101899A. Offers mild conditions, high purity, and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN102311439B reveals novel synthesis for high-purity diazabicyclo intermediates. Enhance solubility and reduce API manufacturing costs with scalable routes.
Patent CN110627786B reveals a novel one-step synthesis for tadalafil intermediates using piperonyl acid chloride, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.